Skip to main content
. Author manuscript; available in PMC: 2013 Dec 4.
Published in final edited form as: In Vivo. 2013 Jul-Aug;27(4):473–484.

Table I.

Data on 4-nitroquinoline 1-oxide (4-NQO)-induced oral and esophageal cancer development in mice.

Treatment groups Number of mice Initial body weight (g) Final body weight (g) Site Number of animal affected Number of dysplasia or tumor mass
Control 10 23.69 ± 1.902 33.63 ± 5.3 Tongue 0 0
Esophagus 0 0
4-NQO
15 μg/ml 10 22.5 ± 1.211 32.23 ± 4.7 Tongue 1 1
Esophagus 4 7
30 μg/ml 10 23.53 ± 1.271 26.14 ± 3.5 Tongue 7 14
Esophagus 8 19
45 μg/ml 10 22.62 ± 1.651 23.97 ± 1.5 Tongue 9 19
Esophagus 8 12